Earningsreport

Q2/2019 6/30/2019 EPS -1.070 ZacksConsensus N/A ActVsEst N/A - N/A

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php